Individuals carrying loss-of-function mutations in the SGLT1 gene are estimated to have a lower risk of developing heart failure, driven by mitigation of postprandial hyperglycemic episodes (Seidelmann et al., 2018). The gene discussed is SLC5A1; the disease is heart failure.